Ferrari MD, et al. Sustained Reduction of Migraine Headache Days in Patients With Episodic Migraine During Months 4 to 6 of Treatment With Galcanezumab. IHC-PO-145. IHC 2019, 5-8 sept. Dublin, Ierland.
Bootcamp voor training in acute neurologie
mei 2024 | Dementie, Epilepsie, Hoofdpijn, Neuro-musculair, Neuro-vasculair